Oppenheimer


Oppenheimer Raises Palo Alto Networks PT To $115 Following Meetings With Management

In a research report issued today, Oppenheimer analyst Shaul Eyal reiterated an Outperform rating on Palo Alto Networks (NYSE:PANW), and raised his price …

Broadcom’s Unique ‘Restructuring’ Story Presents Good Risk/Reward Here, Says Oppenheimer

In a research report released to investors today, analyst Rick Schafer of Oppenheimer reiterated an Outperform rating on Broadcom (NASDAQ:BRCM) with a $48 price target, …

Oppenheimer Initiates Outperform On Liberty TripAdvisor Holdings Shares, $38 PT

In a research report issued yesterday, Oppenheimer analyst Manish Hemrajani initiated coverage on Liberty TripAdvisor Holdings. (NASDAQ:LTRPA) with an Outperform rating and a $38 price target.

Oppenheimer Maintains Perform On Illumina Following 3Q14 Results

In a research report issued to investors today, Oppenheimer analyst Bret Jones maintained a Perform rating on Illumina (NASDAQ:ILMN) following the company’s fourth-quarter …

Oppenheimer Initiates Bullish Stance On Tripadvisor; Sees 12% Upside

In a research report issued yesterday, Oppenheimer analyst Manish Hemrajani maintained an Outperform rating on Tripadvisor (NASDAQ:TRIP) with a price target of $99, …

Oppenheimer Maintains Bullish Bias On Apple Following Earnings

In a research report issued today, Oppenheimer analyst Andrew Uerkwitz reiterated an Outperform rating on Apple (NASDAQ:AAPL) with a $115 price target, following the …

Oppenheimer Remains Bullish On Amazon As AWS Set To Drive 3Q SOI Upside

In a research report sent to investors today, Oppenheimer analyst Jason Helfstein assigned an Outperform rating on Amazon (NASDAQ:AMZN) with a price target …

Chipotle Mexican Grill: Food Cost Worries Provides Buying Opportunity, Says Oppenheimer

In a research report published today, Oppenheimer analyst Brian Bittner assigned an Outperform rating on Chipotle Mexican Grill (NYSEARCA:CMG) with a $775 price target, …

Oppenheimer Assigns Perform On Myriad Genetics On Lowered Expectations For F1Q15

In a research report issued today, Oppenheimer analyst Bret Jones assigned a Perform rating on Myriad Genetics (NASDAQ:MYGN), as lowered guidance led to …

Oppenheimer Reiterates Outperform On Honeywell On The Back Of 4Q14 Earnings

In a research report issued today, Oppenheimer analyst Christopher Glynn reiterated an Outperform rating on Honeywell International (NYSE:HON) with a price target of …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts